Evaluation of insulin antibodies and placental transfer of insulin aspart in pregnant women with type 1 diabetes mellitus

被引：34
|
作者：
McCance, D. R. [1 ]
Damm, P. [2 ]
Mathiesen, E. R. [3 ]
Hod, M. [4 ]
Kaaja, R. [5 ]
Dunne, F.
Jensen, L. E. [6 ]
Mersebach, H. [6 ]
机构：
[1] Royal Victoria Hosp, Reg Ctr Endocrinol & Diabet, Belfast BT12 6BA, Antrim, North Ireland
[2] Univ Copenhagen Hosp, Dept Obstet, Rigshosp, DK-2100 Copenhagen, Denmark
[3] Rigshosp, Dept Endocrinol, DK-2100 Copenhagen, Denmark
[4] Tel Aviv Univ, Sackler Fac Med, Rabin Med Ctr, Helen Schneider Hosp Women,Perinatal Div, IL-49100 Petah Tiqwa, Israel
[5] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland
[6] Novo Nordisk, Global Dev, Bagsvaerd, Denmark
来源：
DIABETOLOGIA | 2008年 / 51卷 / 11期
关键词：
human insulin; insulin antibody; insulin aspart; pregnancy; type; 1; diabetes;
D O I：
10.1007/s00125-008-1120-y
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2141 / 2143
页数：3
相关论文
共 50 条
  • [31] Insulin degludec and insulin degludec/insulin aspart: A guide to their use in diabetes mellitus
    Keating G.M.
    Drugs & Therapy Perspectives, 2013, 29 (10) : 297 - 302
  • [32] Use of insulin lispro in pregnant women with diabetes mellitus
    Rosen, SG
    Engel, SS
    DIABETES, 1998, 47 : A437 - A437
  • [33] Insulin aspart - A review of its use in the management of type 1 and 2 diabetes mellitus
    Chapman, TM
    Noble, S
    Goa, KL
    DRUGS, 2002, 62 (13) : 1945 - 1981
  • [34] INFLUENCE OF INSULIN ANTIBODIES ON PLACENTAL TRANSFER OF INSULIN
    THORELL, J
    ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA, 1964, 61 (01): : 157 - &
  • [35] Sensor-derived glycaemic metrics in pregnant women with type 1 diabetes randomised to faster-acting insulin aspart or insulin aspart: a secondary analysis of the CopenFast trial
    Soholm, J. C.
    Norgaard, S. K.
    Norgaard, K.
    Clausen, T. D.
    Damm, P.
    Mathiesen, E.
    Ringholm, L.
    DIABETOLOGIA, 2024, 67 : S229 - S229
  • [36] Insulinglulisine and aspart insulin are equipotent in intensified insulin therapy of patients with type 2 diabetes mellitus
    Jungmann, E.
    Bolle, J.
    Schmitz, C.
    Snelting, U.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2007, 37 : 67 - 68
  • [37] Insulin degludec/insulin aspart combination for the treatment of type 1 and type 2 diabetes
    Dardano, Angela
    Bianchi, Cristina
    Del Prato, Stefano
    Miccoli, Roberto
    VASCULAR HEALTH AND RISK MANAGEMENT, 2014, 10 : 465 - 475
  • [38] Sensor-derived glycaemic metrics in pregnant women with type 1 diabetes randomised to faster acting insulin aspart or insulin aspart-A secondary analysis of the CopenFast trial
    Soholm, Julie C.
    Norgaard, Sidse K.
    Norgaard, Kirsten
    Clausen, Tine D.
    Damm, Peter
    Mathiesen, Elisabeth R.
    Ringholm, Lene
    DIABETIC MEDICINE, 2025, 42 (01)
  • [39] A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus
    Tim Heise
    Ulrike Hövelmann
    Eric Zijlstra
    Kirstine Stender-Petersen
    Jacob Bonde Jacobsen
    Hanne Haahr
    Drugs & Aging, 2017, 34 : 29 - 38
  • [40] Insulin aspart in adolescent patients with type 1 diabetes
    Tsalikian, E
    Silverstein, J
    Mueller, PG
    DIABETES, 2000, 49 : A127 - A128
12345